United States· US:68382-559_0d11f48c-867f-471c-a74c-9d50f6a76cfd
nitrofurantoin macrocrystals
A nitrofurantoin product containing nitrofurantoin, registered in United States by Zydus Pharmaceuticals (USA) Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nitrofurantoin is registered in 16 of 19 countries.
Countries holding a registration under ATC J01XE01 (nitrofurantoin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Nitrofurantoin · ATC J01XE01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nitrofurantoin costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.66 in United States to $1.32 in Switzerland — a ×2.0 gap.
- United States: $0.66 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Nitrofurantoin · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.32
- IT Italy$0.89
- US United States$0.66 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NITROFURANTOIN
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc.
- Country
- United States (US)
- ATC code
- J01XE01
- ATC class
- Nitrofurantoin
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1168382-559-01
- ndc1168382-559-10
- ndc1168382-559-30
- ndc116838255901100 CAPSULE in 1 BOTTLE (68382-559-01)
- ndc1168382559101000 CAPSULE in 1 BOTTLE (68382-559-10)
- ndc11683825593010 BLISTER PACK in 1 CARTON (68382-559-30) / 10 CAPSULE in 1 BLISTER PACK
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
237 interactions on record for nitrofurantoin.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nitrofurantoin · interactions on record
237 records
- 4 severe
- 108 moderate
- 21 minor
- 103 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nitrofurantoin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMacrodantin 50mg capsulesAdvanz Pharma
- NetherlandsFuradantine MC 50 mg, capsulesAmdipharm Limited
- CzechiaAURUVENLITcon Pharma SE, Praha 8
- IrelandMacrodantin 50 mg hard capsulesAmdipharm Limited
- ItalyNEOFURADANTINGRUNENTHAL ITALIA S.R.L.
- BelgiumFuradantine MC 50 mgAmdipharm
- CanadaJAMP NITROFURANTOINJAMP PHARMA CORPORATION
- NorwayFuradantineMerck
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Furadantin Retard, Nitrofurantoin Agepha
- Belgium · Furadantine Mc, Nitrofurantoin Activase
- Bulgaria · Фуролин
- Cyprus · Furolin, Macrodantin
- Czechia · Nostiriazyn
- Germany · Furadantin Retard, Furadantin Rp
- Denmark · Foragen, Nitrofurantoin "eql Pharma"
- Estonia · Magromag, Nitrofurantoin Orifarm
- Spain · Furantoína
- Finland · Foragen, Furuti
- France · Furadantine
- United Kingdom (Northern Ireland) · Aratoin, Furadantin
- Greece · Furolin, Nitrofurantoin Iasis
- Croatia · Ninur, Nitrofurantoin Galenika
- Hungary · Nitrofurantoin Pharmsol, Nitrofurantoin-Chinoin
- Ireland · Macrobid, Macrodantin
- Iceland · Furadantin
- Italy · Furedan, Nitrofurantoina Doc
- Lithuania · Furadonins, Magromag
- Luxembourg · Furadantine Mc
- Latvia · Furadonīns, Magromag
- Malta · Furolin, Macrodantin
- Netherlands · Foragen, Furabid
- Norway · Foragen, Furadantin
- Portugal · Furadantina Mc, Nitrofurantoin Activase
- Romania · Furolin, Nitrofurantoina Arena
- Sweden · Foragen, Furadantin
- Slovenia · Macrobid, Nitrofurantoin Activase 100 Mg
- Slovakia · Nitrofurantoin Olikla, Nitrofurantoin Pharmevid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be042c33-dfe8-449d-8d76-0120ea85a014 GET /v1/drugs/be042c33-dfe8-449d-8d76-0120ea85a014?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "NITROFURANTOIN",
"productndc": "68382-559",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA205005",
"marketing_category": "ANDA"
}See everything about nitrofurantoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.